EVENTS|NEWS|CONTACT|DONATE

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Read Our Newsletter

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Tag

rivoceranib

Elevar Announces Results from the Angel Trial, A Study of Monotherapy Rivoceranib (Apatinib) In Late-Stage Gastric Cancer Patients

At ESMO 2019, Elevar Therapeutics announced that in a phase 3 trial in gastric cancer patients, rivoceranib did not improve overall survival...

Social Media

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Categories

Foundation News
Press Releases
Research News
Your New Normal

Tags

adenocarcenoma advanced stage alcohol antibody biomarker blood chemoradiotherapy chemotherapy clinical trial clinical trials detection drugs endoscopy Epstein-Barr esophagogastric FDA gastrectomy gastric cancer registry gastroesophageal genes heartburn helicobacter pylori HER2 immunotherapy keytruda lonsurf metastatic nutrition peritoneal postoperative prevention proton pump inhibitor recovery recurrence research risk screening side-effects studies surgery survival treatment tumor virus women

Gastric Cancer Foundation

Tax ID 27-2978173

info@gastriccancer.org

PO Box 338
Millbrae, CA 94030

For Deliveries:
Gastric Cancer Foundation
501 Broadway, #338
Millbrae, CA 94030-1907

Site Map

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Social Feed

Gastric Cancer Foundation

18 hours ago

In a small study, 62% of patients with microsatellite instability–high (MSI-H) gastric cancer responded well to a combination of two immunotherapy treatments, Opdivo) and Yervoy. ... See MoreSee Less

Frontline Nivolumab Combo Shows Enduring Activity in MSI-H Gastric Cancer

www.cancernetwork.com

Phase 2 data may support nivolumab plus low-dose ipilimumab as a promising option in patients with microsatellite instability–high gastric cancer.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

4 days ago

In a small human trial co-authored by Gastric Cancer Foundation grantee Eunyoung Choi of Vanderbilt University, the targeted cancer drug trametinib showed promise in reprogramming early-stage stomach lesions in a way that may prevent them from becoming cancerous. ... See MoreSee Less

Drug shows safety, efficacy for precancerous stomach lesions

news.vumc.org

Cancer drug trametinib shows potential as an interventional therapy to reprogram precancerous gastric lesions.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

3 weeks ago

Jazz Pharmaceuticals' Zihera (zanidatamab) showed promising efficacy in HER2-positive gastric cancer in an early trial. ... See MoreSee Less

Zanidatamab Displays Safety, Efficacy in HER2-Expressing Gastric Cancer

www.cancernetwork.com

Antitumor activity was observed in patients with gastroesophageal adenocarcinoma treated with the combination regardless of chemotherapy type.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

4 weeks ago

Check out this visual guide to gastric cancer from WebMD for tips on prevention, diagnosis, and treatment. ... See MoreSee Less

Guide to Stomach (Gastric) Cancer

www.webmd.com

Diagnosed with stomach cancer? These pictures from WebMD take a look at symptoms, treatment, and lifestyle changes that help you deal with gastric cancer.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

4 weeks ago

Major developments in research and clinical practice are helping address the biggest challenges in gastric cancer, say oncologists at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine. ... See MoreSee Less

Addressing the Biggest Challenges in Stomach Cancer - InventUM

news.med.miami.edu

Sylvester researchers are building upon recent, significant progress to identify effective treatments for stomach cancer.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Subscribe to Our Newsletter

We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.

© 2024 Gastric Cancer Foundation. All Rights Reserved.

EVENTS | NEWS | CONTACT | DONATE

X